Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05668494
Other study ID # One abutment one time study
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date September 1, 2024

Study information

Verified date December 2022
Source University of Belgrade
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This will be a prospective, randomized, controlled, single center clinical trial with 1 year enrollment period, surgical and prosthetic rehabilitation with 1-year post-loading follow-up. A total of 2.0 years of study duration The primary objective is to compare peri-implant hard and soft tissue changes between single implants placed in the posterior mandible and immediately loaded either with definitive (one-time) or provisional abutment.


Description:

Hard tissue contour changes will be assessed using standardized two-dimensional intra-oral radiographs and partial small field of view three-dimensional cone beam CT scans. Soft tissue contour changes will be assessed using superimposition of dental digital models. Inflammatory soft tissue reactions will be evaluated by measurement of respective cytokines' levels.A quantitative evaluation of total bacteria amount of the peri-implant samples. Secondary objectives of this study will be to estimate total bacterial amount (quantitative real-time polymerase chain reaction - qRT-PCR). Bleeding on probing (BoP), full mouth oral hygiene index, periodontal pocket depth (PPD) and keratinized tissue width will also be evaluated. Indication: Patients with need of at least two implants (one per side) in the premolar or molar region in the mandible, bilaterally.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 24
Est. completion date September 1, 2024
Est. primary completion date September 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 50 Years
Eligibility Inclusion Criteria: - Minimum age of 25 years - In need of a one or two implants. - Healed site (healed site defined by restored gingiva, free of inflammation and scar tissue , with a keratinized band of 3mm from crest to muco-gingival junction, and sufficient osseous architecture to receive an implant with a minimal diameter of 3.5 mm). - Mandible second premolar or molar region. - At least one neighboring tooth to be present. - Absence of visible active periapical or periodontal inflammation. - Adequate oral hygiene: PI< 20%, BoP< 20%. - Sufficient occlusal units mesial or distal and antagonizing, including the diastema to be restored: 4 occlusal units. Exclusion Criteria: - Medical condition that contraindicates surgery: ASA -score = III - History of radiotherapy in the head and neck region. - History of Bisphosphonate medication. - Medium smokers = 10 cigarettes per day. - Patients unwilling or incapable of understanding and signing the informed consent. - Active caries. - Presence of inflammation expressed by PPD >4mm and BoP on adjacent teeth. - Active periapical radiolucency or root canal treatment performed < 4 months previous to planned implant insertion on a neighboring tooth to future implant. - Insufficient restorative space. - Interocclusal plane distance < 20mm at planed implant position.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
immediate loading of implants
This is a randomized control clinical trial including 24 implants, immediately loaded with definitive abutment protocol and 24 implants immediately loaded with with temporary abutment protocol

Locations

Country Name City State
Serbia School of Dental Medicine University of Belgrade Belgrad

Sponsors (1)

Lead Sponsor Collaborator
University of Belgrade

Country where clinical trial is conducted

Serbia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Periimplant marginal bone loss Hard tissue changes will be analyzed and followed up at 3, 6 and 12 months by captured intraoral radiographs using a customized radiographic holder. The following landmarks will be measured in order to assess bone remodelling around implants
Mesial distance in mm from first bone to implant contact to implant shoulder (vertical line);
Distal distance in mm from first bone to implant contact to implant shoulder (vertical line) after implant placement.
12 months
See also
  Status Clinical Trial Phase
Recruiting NCT06173791 - Demineralized Bone Allograft Fibers Versus Particulate In Sinus Augmentation N/A
Completed NCT05724706 - An Evaluation of Salivary Oxidant and Antioxidant Levels in Peri-implant Health and Disease
Completed NCT05595746 - Radiological Bone Loss on Different Levels of Dental Implants N/A
Completed NCT05282212 - Point of Care, High Resolution and 3-Dimensional Ultrasonography
Recruiting NCT04054219 - Evaluation of Efficacy and Safety of Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation N/A
Recruiting NCT05241548 - BMAC on PCL Scaffold for Ridge Augmentation N/A
Not yet recruiting NCT03324789 - Comparison Between Single Implant Retained Partial Over-denture and Conventional Partial Denture N/A
Enrolling by invitation NCT05906563 - Evaluation of Melatonin and Metformin Loaded Nanoparticles in the Treatment of Periodontal Intra-bony Defects Phase 2
Completed NCT04286334 - Three-dimensional Bone Regeneration Using Custom-made Meshes With and Without Collagen Membrane N/A